These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33353167)

  • 1. Characterization of In Vitro and In Vivo Metabolism of Antazoline Using Liquid Chromatography-Tandem Mass Spectrometry.
    Giebułtowicz J; Korytowska N; Piotrowski R; Kułakowski P; Latacz G; Szymańska E; Wiśniowska B; Polak S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a novel liquid chromatography/tandem mass spectrometry method for the determination of antazoline in human plasma: Result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study.
    Giebułtowicz J; Piotrowski R; Baran J; Kułakowski P; Wroczyński P
    J Pharm Biomed Anal; 2016 May; 123():113-9. PubMed ID: 26895496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Core-Shell Molecularly Imprinted Nano-Conjugates for Extraction of Antazoline and Hydroxyantazoline from Human Plasma-Material Characterization, Theoretical Analysis and Pharmacokinetics.
    Giebułtowicz J; Korytowska N; Sobiech M; Polak S; Wiśniowska B; Piotrowski R; Kułakowski P; Luliński P
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
    Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tentative identification of in vitro metabolites of 5-APDB, a synthetic benzofuran, by LC-Q/TOF-MS.
    Park JS; Rehman SU; Kim IS; Choi MS; Lee JS; In S; Yoo HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():296-300. PubMed ID: 27595649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of in vitro metabolites of a new anticoccidial drug nitromezuril using HepG2 cells, rat S9 and primary hepatocytes by liquid chromatography/tandem mass spectrometry.
    Zhang K; Li S; Zheng W; Zhang L; Wang C; Wang X; Fei C; Xue F; Wang M
    Rapid Commun Mass Spectrom; 2014 Aug; 28(15):1723-34. PubMed ID: 24975253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry.
    Liu DQ; Karanam BV; Doss GA; Sidler RR; Vincent SH; Hop CE
    Drug Metab Dispos; 2004 Sep; 32(9):1023-31. PubMed ID: 15319345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Cresteil T
    J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry.
    Lahoz A; Donato MT; Picazo L; Gómez-Lechón MJ; Castell JV
    Toxicol In Vitro; 2007 Oct; 21(7):1247-52. PubMed ID: 17521862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry.
    Suchanova B; Kostiainen R; Ketola RA
    Eur J Pharm Sci; 2008 Jan; 33(1):91-9. PubMed ID: 18055188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry.
    Borkar RM; Bhandi MM; Dubey AP; Nandekar PP; Sangamwar AT; Banerjee SK; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():386-99. PubMed ID: 25459938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of in vitro and in vivo metabolism of leelamine using liquid chromatography-tandem mass spectrometry.
    Shrestha R; Jo JJ; Lee D; Lee T; Lee S
    Xenobiotica; 2019 May; 49(5):577-583. PubMed ID: 29790809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of metabolites of sibutramine in primary cultures of rat hepatocytes by liquid chromatography-ion trap mass spectrometry.
    Hakala KS; Link M; Szotakova B; Skalova L; Kostiainen R; Ketola RA
    Anal Bioanal Chem; 2009 Feb; 393(4):1327-36. PubMed ID: 19066859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes.
    Feidt DM; Klein K; Hofmann U; Riedmaier S; Knobeloch D; Thasler WE; Weiss TS; Schwab M; Zanger UM
    Drug Metab Dispos; 2010 Sep; 38(9):1589-97. PubMed ID: 20551241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of flavonolignans in human hepatocytes.
    Vrba J; Papoušková B; Roubalová L; Zatloukalová M; Biedermann D; Křen V; Valentová K; Ulrichová J; Vacek J
    J Pharm Biomed Anal; 2018 Apr; 152():94-101. PubMed ID: 29414024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.